IL12A and colitis: The observed reduction of IL12A mRNA by atorvastatin and rosuvastatin is in line with previous findings indicating that rosuvastatin (0.3 mg/kg/day; 21 days) can significantly reduce the serum level of IL-12 in mice with colitis induced by dextran sulfate sodium (DSS) [26, 34].